Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear components refer to the collective structural and functional elements found within the eukaryotic cell nucleus, including genomic DNA, various RNA species, histones, and regulatory proteins (Source: Molecular Biology of the Cell). These components are essential for fundamental biological processes such as gene expression, DNA replication, and repair, which maintain cellular homeostasis and genomic integrity. However, the term Nuclear components is considered too broad and non-specific to be classified as a single therapeutic target in drug discovery (Source: Nature Reviews Drug Discovery). Instead, specific molecules within the nucleus, such as DNA topoisomerases, polymerases, or histone deacetylases, serve as the actual targets for pharmacological intervention, particularly in oncology and inflammatory diseases. In clinical practice, nuclear components are highly significant in the context of autoimmune disorders, where they act as antigens for antinuclear antibodies (ANAs), serving as critical diagnostic markers for conditions like systemic lupus erythematosus (Source: StatPearls, Antinuclear Antibody).
Drugs targeting nuclear components typically act by intercalating into DNA, inhibiting nuclear enzymes such as topoisomerases or polymerases, or modulating epigenetic states through histone modification (Source: Nature Reviews Cancer).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear component.